Research Progress on Drug Treatment Pathways in the United States,United Kingdom,and Japan
10.3870/j.issn.1004-0781.2025.07.014
- VernacularTitle:美国英国日本药物治疗路径研究进展
- Author:
Cheng SI
1
;
Li LING
;
Danying LI
;
Weihong GE
Author Information
1. 南京中医药大学鼓楼临床医学院,南京 210008;南京大学医学院附属鼓楼医院药学部,南京 210008
- Publication Type:Journal Article
- Keywords:
Drug therapy pathway;
Clinical pathway;
Multidisciplinary collaboration
- From:
Herald of Medicine
2025;44(7):1089-1093
- CountryChina
- Language:Chinese
-
Abstract:
The drug therapy pathway is an important part of the clinical pathway,aiming to enhance the efficiency and quality of healthcare services,optimize the allocation of healthcare resources,enhance patients' adherence to treatment,reduce the rate of medical errors,and ultimately improve patients' treatment outcomes through clear steps of drug therapy.The drug therapy pathway in the United States emphasizes multidisciplinary teamwork,and pharmacists play a key role in the formulation and implementation of the pathway;the drug therapy pathway in the United Kingdom is jointly formulated by the National Health Service of the United Kingdom and the National Institute for Health and Clinical Excellence of the United Kingdom,and pharmacists provide professional advice in the formulation and implementation of the pathway;and the management of the drug therapy pathway in Japan is the responsibility of the Japan Clinical Pathway Society,and pharmacists play an important role in the promotion and implementation of the pathway.Pharmacists play an important role in the promotion and implementation of pathways.This article analyzes the experiences and models of the United States,the United Kingdom,and Japan in the development of drug therapy pathways,to provide a reference for the development of drug therapy pathways in China.
